Cramer's 'Mad Money' Recap: How to Play the Surprising Jobs Report (Update 3)
Cramer says an improving economy means stocks will be heading higher.
06:39PM 12/04/09
Healthcare Stocks: Safe and Speculative
NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio.
12:56PM 11/23/09
Jim Cramer's Portfolios of the Week
Here's what Cramer's been talking about lately.
08:18AM 11/20/09
Cramer's 'Stop Trading!': Bristol-Myers
Jim Cramer discusses Intel, Boeing, Bristol-Myers and more.
03:55PM 11/16/09
'Mad Money Lightning Round': American Express Clicks
Cramer says this well-run company is on fire.
07:24PM 11/09/09
Cramer's 'Mad Money' Recap: Five Stocks for This Bull Market (Final)
Cramer told viewers to check out some stalled stocks that he believes will turn into winners. Click for news from Jim Cramer.
06:34PM 11/09/09
Cramer's 'Mad Money' Follow-Up: Nov. 6
Here's how some of Thursday's 'Mad Money' stocks fared on Friday.
04:49PM 11/06/09
Cramer's 'Mad Money' Recap: The Rich Are Spending Again (Final)
Cramer says the return to luxury bodes well for the retail sector and American Express. Click for news from Jim Cramer.
06:31PM 11/05/09
Allos Therapeutics Closes $93 Million Offering
Allos Therapeutics closes offering for 14 million shares, sees about $93 million in proceeds
04:33PM 10/13/09
Allos Therapeutics Prices And Expands Share Offer
Allos could sell up to 16.1M shares to raise funds to market and research cancer drug Folotyn
10:33AM 10/07/09
Early Movers: Pump Up the Volume
Several small-cap stocks were poised to move on above-average volume during Tuesday's session.
08:56AM 10/06/09
By Alix Steel | By Adam Feuerstein
From the Best of TSC TV: BOSTON (TheStreet) - Adam Feuerstein, senior biotech reporter, talks swine flu, small cap stock, healthcare reform, speculative stocks and Dendreon. Watch this video to see Adam's top biotech stock picks. original air date: 09/29/2009.
05:00PM 10/04/09
By Alix Steel | By Adam Feuerstein
BOSTON (TheStreet) -- Adam Feuerstein, senior biotech reporter, breaks down the biotech stocks you want to know about and how to trade them.
12:00PM 10/02/09
Biotech Mailbag: Cel-Sci, BioElectronics
Readers weigh in on Cel-Sci, BioElectronics, Dendreon, Cell Therapeutics and more.
09:18AM 10/02/09
Biotech Mailbag: Cel-Sci, BioElectronics
Readers weigh in on Cel-Sci, BioElectronics, Dendreon, Cell Therapeutics and more.
08:34AM 10/02/09



Connect with TheStreet